Not provided
Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 5T32HD040672-15 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if women would find it acceptable to receive the HPV vaccine postpartum at the pediatrician's office at the time of their child's two-month well- child visit when offered during the third trimester of pregnancy.
There are a large number of young adult women who have not received any doses of HPV vaccine or are incompletely vaccinated. Recommendation for HPV vaccine could occur during pregnancy with the administration of the vaccine postpartum. Finding a way to make it easy for women to present for vaccination is imperative as this is currently a 3-vaccine series. The investigators are interested in understanding if women would find it acceptable if the investigators discussed and encouraged the vaccine while pregnant with receipt of the vaccine through their child's pediatrician at well-child visits in the postpartum period. The investigators will survey women in the third trimester of pregnancy to determine if they would find this acceptable and follow-up with them after their child's two month pediatric visit to reevaluate their opinion. No doses of the vaccine will be given.
The investigators are also interested in understanding other factors that could affect whether or not women would be interested in receiving the HPV vaccine postpartum. This includes rates of attendance at postpartum visits as well as behavioral, knowledge and demographic characteristics that may be associated with acceptability of receiving the vaccine.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Acceptability of HPV vaccination | Estimation of the proportion of women indicating that they would be willing to receive the HPV vaccine postpartum at pediatric well-child visits if offered in the third trimester of pregnancy | At time of enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of women attending postpartum visits | Estimation of the proportion of women who attend postpartum visits with their obstetric care providers | At time of follow-up which will occur 8 weeks after delivery. This could occur up to 5 months after enrollment. |
| Estimate of baseline prevalence of prior HPV vaccination in study population |
| Measure | Description | Time Frame |
|---|---|---|
| Attitudes and beliefs regarding HPV immunization | This will be assessed using the Carolina HPV Immunization Attitudes and Belief Scale | at time of enrollment |
| Health Literacy | Health literacy will be screened using the "Newest Vital Sign" Measure |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Women will be recruited from the hospital based UNC Obstetric and Gynecology (UOG) Clinic including the resident clinic, faculty clinics and maternal fetal medicine clinics. The UOG Clinic cares for a diverse population of women from the immediate geographical area as well as referrals from 14 surrounding funded health centers.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kimberly Kilfoyle, MD | University of North Carolina, Chapel Hill | Principal Investigator |
| Lisa Rahandale, MD | University of North Carolina, Chapel Hill | Study Chair |
Not provided
Not provided
Not provided
Not provided
Not provided
Participants eligible for participation based on maternal age and gestational age will be screened for prior doses of HPV vaccine by self-report. Number of participants with self-report of prior HPV vaccination will be recorded and baseline prevalence from our population will be determined. |
| at time of enrollment |
| at time of enrollment |
| HPV and HPV vaccine Knowledge | A series of questions will be used to determine baseline knowledge of HPV and HPV vaccination | at time of enrollment |